SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Jul 01
 +0.60 / +1.43%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").


1 month+3.39% 3 years+2.87%
3 months-6.91% 5 years+0.62%
1 year-17.77% Since inception+8.31%
Data through 07/02/2022

Quote Details

Previous close$42.00
Open day’s range41.92 – 42.66
Net asset value (NAV)42.62 (07/01/2022)
Daily volume40,040
Average volume (3 months)66,884
Data as of 3:59pm ET, 07/01/2022

Peer Comparisonvs. Health ETFs

Performance 5-yr return+0.62%+11.31%
Expense Gross exp ratio0.35%1.01%
Risk 5 year sharpe ratio0.100.52
Net assets$186.9M$1.9B
Average market cap$14.3B$43.0B
Average P/E20.822.2
Dividend / Share--0.27%


VHT Vanguard Health Care Index Fund ETF Shar...
IEHS iShares Evolved U.S. Healthcare Staples ...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
VTRS Viatris Inc5.80%
LLY Eli Lilly and Co5.58%
MRK Merck5.57%
BMY Bristol-Myers Squibb5.19%
RPRX Royalty Pharma PLC5.09%
CTLT Catalent Inc5.08%
JNJ Johnson & Johnson5.02%
OGN Organon & Co5.02%
PFE Pfizer5.00%
PRGO Perrigo Company PLC5.00%